Trademarkia Logo

Australia

AU$
SYLUKI
Cancelled: Cancelled at the request of IB

Last updated on 9 Nov 2017

Owner Info

Millennium Pharmaceuticals, Inc.

40 Landsdowne Street

Cambridge, MA 02139, UNITED STATES OF AMERICA

Serial Number

1560072 filed on 5 Apr 2013

Correspondent

Takeda GmbH

Byk-Gulden-Str. 2,

78467 Konstanz,

GERMANY

SYLUKI

Classification Information


Class [005]
Pharmaceuticals for the prevention and treatment of cancer and of auto-immune and inflammation diseases

Mark Details


Serial Number

1560072

Registered On

5 Apr 2013

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

27 Nov 2012

Mark Type

US

Legal History


Show more

Status DateAction Taken
9th Nov 2017Cancellation of Entry in Register Published
2th Nov 2017Cancel IP Right
17th Aug 2017General Correspondence (Application or Registration)
7th May 2015Amendment to Application/Registration
22nd Aug 2013IP Right Registration Published
14th Aug 2013Register Trade Mark
14th Aug 2013Application Status
6th Jun 2013IP Right Acceptance Published
6th Jun 2013IP Right Filed Published
4th Jun 2013Clear Examination report approved